BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21933802)

  • 1. Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population.
    Shanmugam N; Boerdlein A; Proff J; Ong P; Valencia O; Maier SK; Bauer WR; Paul V; Sack S
    Europace; 2012 Feb; 14(2):230-7. PubMed ID: 21933802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of Implanted-Device-Detected Atrial High-Rate Episode Is Associated With Future Heart Failure Events - Clinical Significance of Asymptomatic Atrial Fibrillation in Patients With Implantable Cardiac Electronic Devices.
    Nishinarita R; Niwano S; Fukaya H; Oikawa J; Nabeta T; Matsuura G; Arakawa Y; Kobayashi S; Shirakawa Y; Horiguchi A; Nakamura H; Ishizue N; Kishihara J; Satoh A; Ako J
    Circ J; 2019 Mar; 83(4):736-742. PubMed ID: 30814400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial high-rate episodes predict clinical outcome in patients with cardiac resynchronization therapy.
    Jacobsson J; Platonov PG; Reitan C; Carlsson J; Borgquist R
    Scand Cardiovasc J; 2017 Apr; 51(2):74-81. PubMed ID: 27841021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation burden and subsequent heart failure events in patients with cardiac resynchronization therapy devices.
    Tanawuttiwat T; Lande J; Smeets P; Gerritse B; Nazarian S; Guallar E; Cheng A
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1519-1526. PubMed ID: 32162753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of atrial high rate episodes predicts atrial fibrillation and thromboembolic events in patients with cardiac resynchronization therapy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Nielsen JC
    Heart Rhythm; 2015 Dec; 12(12):2368-75. PubMed ID: 26164377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial Dyssynchrony: A New Predictor for Atrial High-Rate Episodes in Patients with Cardiac Resynchronization Therapy.
    Xu C; Chen K; Yu F; Wang Q; Su H; Yang D; Xu J; Yan J
    Cardiology; 2019; 144(1-2):18-26. PubMed ID: 31476753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics.
    Leclercq C; Padeletti L; Cihák R; Ritter P; Milasinovic G; Gras D; Paul V; Van Gelder IC; Stellbrink C; Rieger G; Corbucci G; Albers B; Daubert JC;
    Europace; 2010 Jan; 12(1):71-7. PubMed ID: 19864311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronization therapy in patients with atrial fibrillation: a 2-year follow-up study.
    Eisen A; Nevzorov R; Goldenberg G; Kuznitz H; Porter A; Golovtziner G; Strasberg B; Haim M
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):872-7. PubMed ID: 23594360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Device-detected atrial tachyarrhythmias: what do we know?
    Healey JS
    Europace; 2012 Feb; 14(2):157-8. PubMed ID: 21987342
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistent atrial fibrillation worsens heart rate variability, activity and heart rate, as shown by a continuous monitoring by implantable biventricular pacemakers in heart failure patients.
    Puglisi A; Gasparini M; Lunati M; Sassara M; Padeletti L; Landolina M; Botto GL; Vincenti A; Bianchi S; Denaro A; Grammatico A; Boriani G;
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):693-701. PubMed ID: 18328039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chronic atrial fibrillation in patients with severe heart failure and indication for CRT: data of two registries with 711 patients (1999-2006 and 2007-6/2008).
    Luedorff G; Grove R; Kowalski M; Wolff E; Thale J; Kranig W
    Herzschrittmacherther Elektrophysiol; 2011 Dec; 22(4):226-32. PubMed ID: 22160274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of an implantable defibrillator multi-sensor heart failure index and an apnea index for the prediction of atrial high-rate events.
    Bertini M; Vitali F; D'Onofrio A; Vitulano G; Calò L; Savarese G; Santobuono VE; Dello Russo A; Mattera A; Santoro A; Calvanese R; Arena G; Amellone C; Ziacchi M; Palmisano P; Santini L; Mazza A; Campari M; Valsecchi S; Boriani G
    Europace; 2023 Apr; 25(4):1467-1474. PubMed ID: 36881780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study.
    Whitbeck MG; Charnigo RJ; Shah J; Morales G; Leung SW; Fornwalt B; Bailey AL; Ziada K; Sorrell VL; Zegarra MM; Thompson J; Hosn NA; Campbell CL; Gurley J; Anaya P; Booth DC; Di Biase L; Natale A; Smyth S; Moliterno DJ; Elayi CS;
    Europace; 2014 Jun; 16(6):803-11. PubMed ID: 24368753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation incidence and impact of biventricular pacing on long-term outcome in patients with heart failure treated with cardiac resynchronization therapy.
    Jacobsson J; Reitan C; Carlson J; Borgquist R; Platonov PG
    BMC Cardiovasc Disord; 2019 Aug; 19(1):195. PubMed ID: 31409276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST).
    Glotzer TV; Hellkamp AS; Zimmerman J; Sweeney MO; Yee R; Marinchak R; Cook J; Paraschos A; Love J; Radoslovich G; Lee KL; Lamas GA;
    Circulation; 2003 Apr; 107(12):1614-9. PubMed ID: 12668495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 levels and the prediction of atrial high-rate episodes in patients with cardiac resynchronization therapy.
    Aksan G; Yanık A; Yontar OC; Gedikli Ö; Arslan U; Soylu K
    J Investig Med; 2021 Jan; 69(1):20-27. PubMed ID: 32994201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: Results of the Adaptive Cardiac Resynchronization Therapy Trial.
    Birnie D; Hudnall H; Lemke B; Aonuma K; Lee KL; Gasparini M; Gorcsan J; Cerkvenik J; Martin DO
    Heart Rhythm; 2017 Dec; 14(12):1820-1825. PubMed ID: 28893549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy.
    Caldwell JC; Contractor H; Petkar S; Ali R; Clarke B; Garratt CJ; Neyses L; Mamas MA
    Europace; 2009 Oct; 11(10):1295-300. PubMed ID: 19648586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of a multi-sensor implantable defibrillator algorithm for heart failure monitoring in the presence of atrial fibrillation.
    Boriani G; Bertini M; Manzo M; Calò L; Santini L; Savarese G; Dello Russo A; Santobuono VE; Lavalle C; Viscusi M; Amellone C; Calvanese R; Santoro A; Rapacciuolo A; Ziacchi M; Arena G; Imberti JF; Campari M; Valsecchi S; D'Onofrio A
    Europace; 2023 Aug; 25(9):. PubMed ID: 37656991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.